Matinas is focused on improving the intracellular delivery of critical therapeutics through its LNC delivery platform and is developing its own portfolio of products and partnering with leading pharma companies to develop new formulations that take full advantage of the LNC platform.

Biotechnology

Matinas BioPharma

Jerome D. Jabbour

Frank Calamusa

Thomas J. Hoover

Hui Liu

Keith A. Kucinski

Theresa Matkovits

James J. Ferguson

The executive team at Matinas BioPharma has a history of experience in the field of CMC, nanoparticle gene delivery formulation, and mRNA formulation & delivery. They also have a history of education in polymer chemistry from the University of Michigan.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Matinas BioPharma

Board of Directors

Leadership Team